Lip GYH - Search Results

1

Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry.

Krittayaphong R, Pumprueg S, Ratanasumawong K, Sairat P, Lip GYH; COOL-AF Investigators. Krittayaphong R, et al. Among authors: lip gyh. Clin Interv Aging. 2021 Oct 12;16:1835-1846. doi: 10.2147/CIA.S335321. eCollection 2021. Clin Interv Aging. 2021. PMID: 34675498 Free PMC article.

2

Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.

Lip GY, Lane D, Van Walraven C, Hart RG. Lip GY, et al. Stroke. 2006 Sep;37(9):2294-300. doi: 10.1161/01.STR.0000236840.00467.84. Epub 2006 Aug 3. Stroke. 2006. PMID: 16888271

3

Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.

Varughese GI, Patel JV, Tomson J, Lip GY. Varughese GI, et al. Heart. 2007 Apr;93(4):495-9. doi: 10.1136/hrt.2006.099374. Epub 2006 Sep 27. Heart. 2007. PMID: 17005711 Free PMC article.

4

Platelet adhesion in atrial fibrillation.

Choudhury A, Chung I, Blann A, Lip GY. Choudhury A, et al. Thromb Res. 2007;120(4):623-9. doi: 10.1016/j.thromres.2006.12.008. Epub 2007 Jan 23. Thromb Res. 2007. PMID: 17250878

5

Effect of hypertension on anticoagulated patients with atrial fibrillation.

Lip GY, Frison L, Grind M; SPORTIF Invetigators. Lip GY, et al. Eur Heart J. 2007 Mar;28(6):752-9. doi: 10.1093/eurheartj/ehl504. Epub 2007 Feb 8. Eur Heart J. 2007. PMID: 17289744 Clinical Trial.

6

Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.

Lip GY, Frison L, Grind M. Lip GY, et al. J Intern Med. 2007 Jun;261(6):577-86. doi: 10.1111/j.1365-2796.2007.01780.x. J Intern Med. 2007. PMID: 17547713 Free article.

7

Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.

Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY. Ruiz-Nodar JM, et al. J Am Coll Cardiol. 2008 Feb 26;51(8):818-25. doi: 10.1016/j.jacc.2007.11.035. J Am Coll Cardiol. 2008. PMID: 18294566 Free article.

8

Antithrombotic treatment in atrial fibrillation.

Lip GY, Boos CJ. Lip GY, et al. Postgrad Med J. 2008 May;84(991):252-8. doi: 10.1136/hrt.2005.066944. Postgrad Med J. 2008. PMID: 18508982 Review.

9

Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation.

Ruiz-Nodar JM, Marín F, Sánchez-Payá J, Hurtado JA, Valencia-Martín J, Manzano-Fernández S, Roldán V, Pérez-Andreu V, Sogorb F, Valdés M, Lip GY. Ruiz-Nodar JM, et al. Eur Heart J. 2009 Apr;30(8):932-9. doi: 10.1093/eurheartj/ehp045. Epub 2009 Feb 26. Eur Heart J. 2009. PMID: 19246502

10

Atrial fibrillation (chronic).

Boos CJ, Lane DA, Lip GY. Boos CJ, et al. BMJ Clin Evid. 2008 Apr 30;2008:0217. BMJ Clin Evid. 2008. PMID: 19450316 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,661 results

Search Page

Filters